nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Urinary incontinence—Capecitabine—kidney cancer	0.00244	0.00491	CcSEcCtD
Mepivacaine—Shock—Pazopanib—kidney cancer	0.00244	0.00491	CcSEcCtD
Mepivacaine—Erythema—Everolimus—kidney cancer	0.0024	0.00483	CcSEcCtD
Mepivacaine—Hyperhidrosis—Pazopanib—kidney cancer	0.0024	0.00482	CcSEcCtD
Mepivacaine—Chills—Erlotinib—kidney cancer	0.00239	0.0048	CcSEcCtD
Mepivacaine—Paralysis—Doxorubicin—kidney cancer	0.00235	0.00472	CcSEcCtD
Mepivacaine—Bradycardia—Sunitinib—kidney cancer	0.00235	0.00471	CcSEcCtD
Mepivacaine—Somnolence—Temsirolimus—kidney cancer	0.00234	0.00471	CcSEcCtD
Mepivacaine—Back pain—Everolimus—kidney cancer	0.00232	0.00467	CcSEcCtD
Mepivacaine—Erythema—Erlotinib—kidney cancer	0.00232	0.00466	CcSEcCtD
Mepivacaine—Vision blurred—Everolimus—kidney cancer	0.00226	0.00455	CcSEcCtD
Mepivacaine—Tremor—Everolimus—kidney cancer	0.00225	0.00452	CcSEcCtD
Mepivacaine—Back pain—Erlotinib—kidney cancer	0.00224	0.0045	CcSEcCtD
Mepivacaine—Tinnitus—Sorafenib—kidney cancer	0.00223	0.00449	CcSEcCtD
Mepivacaine—Paraesthesia—Pazopanib—kidney cancer	0.00223	0.00448	CcSEcCtD
Mepivacaine—Agitation—Everolimus—kidney cancer	0.00221	0.00443	CcSEcCtD
Mepivacaine—Somnolence—Pazopanib—kidney cancer	0.00221	0.00443	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—kidney cancer	0.0022	0.00443	CcSEcCtD
Mepivacaine—Angioedema—Everolimus—kidney cancer	0.00219	0.00441	CcSEcCtD
Mepivacaine—Syncope—Everolimus—kidney cancer	0.00215	0.00433	CcSEcCtD
Mepivacaine—Cardiac arrest—Paclitaxel—kidney cancer	0.00213	0.00427	CcSEcCtD
Mepivacaine—Loss of consciousness—Everolimus—kidney cancer	0.00211	0.00424	CcSEcCtD
Mepivacaine—Convulsion—Vinblastine—kidney cancer	0.00209	0.0042	CcSEcCtD
Mepivacaine—Erythema—Sorafenib—kidney cancer	0.00208	0.00419	CcSEcCtD
Mepivacaine—Body temperature increased—Temsirolimus—kidney cancer	0.00208	0.00418	CcSEcCtD
Mepivacaine—Swelling—Capecitabine—kidney cancer	0.00208	0.00418	CcSEcCtD
Mepivacaine—Hypertension—Vinblastine—kidney cancer	0.00208	0.00418	CcSEcCtD
Mepivacaine—Sweating—Vincristine—kidney cancer	0.00208	0.00418	CcSEcCtD
Mepivacaine—Convulsion—Everolimus—kidney cancer	0.00208	0.00418	CcSEcCtD
Mepivacaine—Syncope—Erlotinib—kidney cancer	0.00208	0.00417	CcSEcCtD
Mepivacaine—Hypertension—Everolimus—kidney cancer	0.00207	0.00417	CcSEcCtD
Mepivacaine—Chills—Sunitinib—kidney cancer	0.00207	0.00415	CcSEcCtD
Mepivacaine—Anxiety—Everolimus—kidney cancer	0.00204	0.00409	CcSEcCtD
Mepivacaine—Loss of consciousness—Erlotinib—kidney cancer	0.00204	0.00409	CcSEcCtD
Mepivacaine—Erythema—Sunitinib—kidney cancer	0.00201	0.00403	CcSEcCtD
Mepivacaine—Sweating—Gemcitabine—kidney cancer	0.00197	0.00397	CcSEcCtD
Mepivacaine—Anxiety—Erlotinib—kidney cancer	0.00197	0.00395	CcSEcCtD
Mepivacaine—Oedema—Everolimus—kidney cancer	0.00196	0.00394	CcSEcCtD
Mepivacaine—Chills—Dactinomycin—kidney cancer	0.00196	0.00393	CcSEcCtD
Mepivacaine—Hypersensitivity—Temsirolimus—kidney cancer	0.00194	0.0039	CcSEcCtD
Mepivacaine—Back pain—Sunitinib—kidney cancer	0.00194	0.0039	CcSEcCtD
Mepivacaine—Shock—Everolimus—kidney cancer	0.00193	0.00387	CcSEcCtD
Mepivacaine—Tachycardia—Everolimus—kidney cancer	0.00191	0.00384	CcSEcCtD
Mepivacaine—Angioedema—Sorafenib—kidney cancer	0.0019	0.00383	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—kidney cancer	0.0019	0.00382	CcSEcCtD
Mepivacaine—Hyperhidrosis—Everolimus—kidney cancer	0.00189	0.00381	CcSEcCtD
Mepivacaine—Oedema—Erlotinib—kidney cancer	0.00189	0.0038	CcSEcCtD
Mepivacaine—Asthenia—Temsirolimus—kidney cancer	0.00189	0.0038	CcSEcCtD
Mepivacaine—Sweating increased—Paclitaxel—kidney cancer	0.00188	0.00379	CcSEcCtD
Mepivacaine—Syncope—Sorafenib—kidney cancer	0.00187	0.00376	CcSEcCtD
Mepivacaine—Pruritus—Temsirolimus—kidney cancer	0.00186	0.00375	CcSEcCtD
Mepivacaine—Shock—Erlotinib—kidney cancer	0.00186	0.00374	CcSEcCtD
Mepivacaine—Angioedema—Sunitinib—kidney cancer	0.00183	0.00368	CcSEcCtD
Mepivacaine—Loss of consciousness—Sorafenib—kidney cancer	0.00183	0.00368	CcSEcCtD
Mepivacaine—Hypotension—Everolimus—kidney cancer	0.00183	0.00368	CcSEcCtD
Mepivacaine—Hypertension—Sorafenib—kidney cancer	0.0018	0.00362	CcSEcCtD
Mepivacaine—Asthenia—Pazopanib—kidney cancer	0.00178	0.00358	CcSEcCtD
Mepivacaine—Paraesthesia—Vinblastine—kidney cancer	0.00177	0.00355	CcSEcCtD
Mepivacaine—Paraesthesia—Everolimus—kidney cancer	0.00176	0.00354	CcSEcCtD
Mepivacaine—Pruritus—Pazopanib—kidney cancer	0.00176	0.00353	CcSEcCtD
Mepivacaine—Cardiac arrest—Capecitabine—kidney cancer	0.00175	0.00351	CcSEcCtD
Mepivacaine—Urinary retention—Capecitabine—kidney cancer	0.00175	0.00351	CcSEcCtD
Mepivacaine—Somnolence—Everolimus—kidney cancer	0.00174	0.0035	CcSEcCtD
Mepivacaine—Dizziness—Temsirolimus—kidney cancer	0.00174	0.0035	CcSEcCtD
Mepivacaine—Convulsion—Sunitinib—kidney cancer	0.00174	0.00349	CcSEcCtD
Mepivacaine—Hypertension—Sunitinib—kidney cancer	0.00173	0.00348	CcSEcCtD
Mepivacaine—Anaphylactic shock—Sorafenib—kidney cancer	0.0017	0.00342	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—kidney cancer	0.00168	0.00338	CcSEcCtD
Mepivacaine—Vomiting—Temsirolimus—kidney cancer	0.00167	0.00337	CcSEcCtD
Mepivacaine—Shock—Sorafenib—kidney cancer	0.00167	0.00336	CcSEcCtD
Mepivacaine—Chills—Gemcitabine—kidney cancer	0.00166	0.00333	CcSEcCtD
Mepivacaine—Headache—Temsirolimus—kidney cancer	0.00165	0.00332	CcSEcCtD
Mepivacaine—Dizziness—Pazopanib—kidney cancer	0.00164	0.0033	CcSEcCtD
Mepivacaine—Back pain—Vincristine—kidney cancer	0.00164	0.0033	CcSEcCtD
Mepivacaine—Oedema—Sunitinib—kidney cancer	0.00164	0.00329	CcSEcCtD
Mepivacaine—Shock—Sunitinib—kidney cancer	0.00161	0.00324	CcSEcCtD
Mepivacaine—Erythema—Gemcitabine—kidney cancer	0.00161	0.00323	CcSEcCtD
Mepivacaine—Vomiting—Pazopanib—kidney cancer	0.00158	0.00317	CcSEcCtD
Mepivacaine—Bradycardia—Paclitaxel—kidney cancer	0.00158	0.00317	CcSEcCtD
Mepivacaine—Nausea—Temsirolimus—kidney cancer	0.00156	0.00314	CcSEcCtD
Mepivacaine—Agitation—Vincristine—kidney cancer	0.00156	0.00313	CcSEcCtD
Mepivacaine—Back pain—Gemcitabine—kidney cancer	0.00156	0.00313	CcSEcCtD
Mepivacaine—Headache—Pazopanib—kidney cancer	0.00155	0.00312	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—kidney cancer	0.00155	0.00311	CcSEcCtD
Mepivacaine—Body temperature increased—Everolimus—kidney cancer	0.00155	0.00311	CcSEcCtD
Mepivacaine—Sweating increased—Capecitabine—kidney cancer	0.00155	0.00311	CcSEcCtD
Mepivacaine—Body temperature increased—Erlotinib—kidney cancer	0.00149	0.003	CcSEcCtD
Mepivacaine—Nausea—Pazopanib—kidney cancer	0.00147	0.00296	CcSEcCtD
Mepivacaine—Paraesthesia—Sunitinib—kidney cancer	0.00147	0.00295	CcSEcCtD
Mepivacaine—Convulsion—Vincristine—kidney cancer	0.00147	0.00295	CcSEcCtD
Mepivacaine—Hypertension—Vincristine—kidney cancer	0.00146	0.00294	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—L1CAM—kidney cancer	0.00146	0.0029	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SPTBN4—kidney cancer	0.00146	0.0029	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Vinblastine—kidney cancer	0.00145	0.00291	CcSEcCtD
Mepivacaine—Hypersensitivity—Everolimus—kidney cancer	0.00144	0.0029	CcSEcCtD
Mepivacaine—Tinnitus—Paclitaxel—kidney cancer	0.00144	0.0029	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—EPAS1—kidney cancer	0.00142	0.00283	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HNF1A—kidney cancer	0.00142	0.00283	CbGpPWpGaD
Mepivacaine—Asthenia—Vinblastine—kidney cancer	0.00141	0.00284	CcSEcCtD
Mepivacaine—Asthenia—Everolimus—kidney cancer	0.00141	0.00283	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—L1CAM—kidney cancer	0.00139	0.00277	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SPTBN4—kidney cancer	0.00139	0.00277	CbGpPWpGaD
Mepivacaine—Hypertension—Gemcitabine—kidney cancer	0.00139	0.00279	CcSEcCtD
Mepivacaine—Chills—Paclitaxel—kidney cancer	0.00139	0.00279	CcSEcCtD
Mepivacaine—Pruritus—Everolimus—kidney cancer	0.00139	0.00279	CcSEcCtD
Mepivacaine—Anaphylactic shock—Vincristine—kidney cancer	0.00138	0.00278	CcSEcCtD
Mepivacaine—Oedema—Vincristine—kidney cancer	0.00138	0.00278	CcSEcCtD
Mepivacaine—Asthenia—Erlotinib—kidney cancer	0.00136	0.00273	CcSEcCtD
Mepivacaine—Urticaria—Sorafenib—kidney cancer	0.00135	0.00272	CcSEcCtD
Mepivacaine—Erythema—Paclitaxel—kidney cancer	0.00135	0.00271	CcSEcCtD
Mepivacaine—Body temperature increased—Sorafenib—kidney cancer	0.00134	0.0027	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—SPTBN4—kidney cancer	0.00134	0.00266	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SPTBN4—kidney cancer	0.00134	0.00266	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—L1CAM—kidney cancer	0.00134	0.00266	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—L1CAM—kidney cancer	0.00134	0.00266	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Vincristine—kidney cancer	0.00134	0.00269	CcSEcCtD
Mepivacaine—Pruritus—Erlotinib—kidney cancer	0.00134	0.00269	CcSEcCtD
Mepivacaine—Tension—Paclitaxel—kidney cancer	0.00132	0.00266	CcSEcCtD
Mepivacaine—Oedema—Gemcitabine—kidney cancer	0.00131	0.00264	CcSEcCtD
Mepivacaine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00131	0.00264	CcSEcCtD
Mepivacaine—Nervousness—Paclitaxel—kidney cancer	0.00131	0.00263	CcSEcCtD
Mepivacaine—Back pain—Paclitaxel—kidney cancer	0.0013	0.00262	CcSEcCtD
Mepivacaine—Dizziness—Vinblastine—kidney cancer	0.0013	0.00261	CcSEcCtD
Mepivacaine—Dizziness—Everolimus—kidney cancer	0.0013	0.0026	CcSEcCtD
Mepivacaine—Body temperature increased—Sunitinib—kidney cancer	0.00129	0.0026	CcSEcCtD
Mepivacaine—Hypotension—Vincristine—kidney cancer	0.00129	0.0026	CcSEcCtD
Mepivacaine—Bradycardia—Capecitabine—kidney cancer	0.00129	0.0026	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—KDR—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—L1CAM—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SPTBN4—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—L1CAM—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SPTBN4—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—PAK1—kidney cancer	0.00129	0.00257	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00129	0.00256	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CER1—kidney cancer	0.00127	0.00253	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—L1CAM—kidney cancer	0.00127	0.00253	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SPTBN4—kidney cancer	0.00127	0.00253	CbGpPWpGaD
Mepivacaine—Vision blurred—Paclitaxel—kidney cancer	0.00127	0.00255	CcSEcCtD
Mepivacaine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00127	0.00255	CcSEcCtD
Mepivacaine—Tremor—Paclitaxel—kidney cancer	0.00126	0.00254	CcSEcCtD
Mepivacaine—Hypersensitivity—Sorafenib—kidney cancer	0.00125	0.00252	CcSEcCtD
Mepivacaine—Vomiting—Vinblastine—kidney cancer	0.00125	0.00251	CcSEcCtD
Mepivacaine—Dizziness—Erlotinib—kidney cancer	0.00125	0.00251	CcSEcCtD
Mepivacaine—Vomiting—Everolimus—kidney cancer	0.00125	0.0025	CcSEcCtD
Mepivacaine—Paraesthesia—Vincristine—kidney cancer	0.00124	0.0025	CcSEcCtD
Mepivacaine—Agitation—Paclitaxel—kidney cancer	0.00124	0.00249	CcSEcCtD
Mepivacaine—Headache—Vinblastine—kidney cancer	0.00123	0.00248	CcSEcCtD
Mepivacaine—Angioedema—Paclitaxel—kidney cancer	0.00123	0.00247	CcSEcCtD
Mepivacaine—Headache—Everolimus—kidney cancer	0.00123	0.00247	CcSEcCtD
Mepivacaine—Hypotension—Gemcitabine—kidney cancer	0.00123	0.00247	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—kidney cancer	0.00122	0.00246	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00122	0.00246	CcSEcCtD
Mepivacaine—Asthenia—Sorafenib—kidney cancer	0.00122	0.00245	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—CER1—kidney cancer	0.00122	0.00242	CbGpPWpGaD
Mepivacaine—Syncope—Paclitaxel—kidney cancer	0.00121	0.00243	CcSEcCtD
Mepivacaine—Hypersensitivity—Sunitinib—kidney cancer	0.00121	0.00242	CcSEcCtD
Mepivacaine—Pruritus—Sorafenib—kidney cancer	0.0012	0.00242	CcSEcCtD
Mepivacaine—Vomiting—Erlotinib—kidney cancer	0.0012	0.00242	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—UNC5C—kidney cancer	0.0012	0.00238	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—KIT—kidney cancer	0.00119	0.00237	CbGpPWpGaD
Mepivacaine—Headache—Erlotinib—kidney cancer	0.00118	0.00238	CcSEcCtD
Mepivacaine—Tinnitus—Capecitabine—kidney cancer	0.00118	0.00238	CcSEcCtD
Mepivacaine—Loss of consciousness—Paclitaxel—kidney cancer	0.00118	0.00238	CcSEcCtD
Mepivacaine—Paraesthesia—Gemcitabine—kidney cancer	0.00118	0.00237	CcSEcCtD
Mepivacaine—Asthenia—Sunitinib—kidney cancer	0.00117	0.00236	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—CER1—kidney cancer	0.00117	0.00233	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CER1—kidney cancer	0.00117	0.00233	CbGpPWpGaD
Mepivacaine—Nausea—Vinblastine—kidney cancer	0.00117	0.00235	CcSEcCtD
Mepivacaine—Somnolence—Gemcitabine—kidney cancer	0.00117	0.00235	CcSEcCtD
Mepivacaine—Convulsion—Paclitaxel—kidney cancer	0.00117	0.00235	CcSEcCtD
Mepivacaine—Nausea—Everolimus—kidney cancer	0.00116	0.00234	CcSEcCtD
Mepivacaine—Hypertension—Paclitaxel—kidney cancer	0.00116	0.00234	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—HNF1B—kidney cancer	0.00116	0.00231	CbGpPWpGaD
Mepivacaine—Pruritus—Sunitinib—kidney cancer	0.00116	0.00233	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—HNF1A—kidney cancer	0.00115	0.00229	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EPAS1—kidney cancer	0.00115	0.00229	CbGpPWpGaD
Mepivacaine—Anxiety—Paclitaxel—kidney cancer	0.00114	0.0023	CcSEcCtD
Mepivacaine—Hypersensitivity—Dactinomycin—kidney cancer	0.00114	0.00229	CcSEcCtD
Mepivacaine—Chills—Capecitabine—kidney cancer	0.00114	0.00229	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—CER1—kidney cancer	0.00113	0.00225	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CER1—kidney cancer	0.00113	0.00225	CbGpPWpGaD
Mepivacaine—Cardiac arrest—Doxorubicin—kidney cancer	0.00113	0.00226	CcSEcCtD
Mepivacaine—Dizziness—Sorafenib—kidney cancer	0.00112	0.00226	CcSEcCtD
Mepivacaine—Nausea—Erlotinib—kidney cancer	0.00112	0.00226	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—kidney cancer	0.00111	0.00223	CcSEcCtD
Mepivacaine—Erythema—Capecitabine—kidney cancer	0.00111	0.00222	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—HNF1A—kidney cancer	0.0011	0.00219	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EPAS1—kidney cancer	0.0011	0.00219	CbGpPWpGaD
Mepivacaine—Oedema—Paclitaxel—kidney cancer	0.0011	0.00221	CcSEcCtD
Mepivacaine—Anaphylactic shock—Paclitaxel—kidney cancer	0.0011	0.00221	CcSEcCtD
Mepivacaine—Body temperature increased—Vincristine—kidney cancer	0.00109	0.0022	CcSEcCtD
Mepivacaine—Dizziness—Sunitinib—kidney cancer	0.00108	0.00218	CcSEcCtD
Mepivacaine—Shock—Paclitaxel—kidney cancer	0.00108	0.00217	CcSEcCtD
Mepivacaine—Vomiting—Sorafenib—kidney cancer	0.00108	0.00217	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL13—kidney cancer	0.00108	0.00215	CbGpPWpGaD
Mepivacaine—Tachycardia—Paclitaxel—kidney cancer	0.00107	0.00216	CcSEcCtD
Mepivacaine—Back pain—Capecitabine—kidney cancer	0.00107	0.00215	CcSEcCtD
Mepivacaine—Headache—Sorafenib—kidney cancer	0.00107	0.00214	CcSEcCtD
Mepivacaine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00106	0.00214	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—EPAS1—kidney cancer	0.00106	0.00211	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EPAS1—kidney cancer	0.00106	0.00211	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HNF1A—kidney cancer	0.00106	0.00211	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HNF1A—kidney cancer	0.00106	0.00211	CbGpPWpGaD
Mepivacaine—Vision blurred—Capecitabine—kidney cancer	0.00104	0.00209	CcSEcCtD
Mepivacaine—Vomiting—Sunitinib—kidney cancer	0.00104	0.00209	CcSEcCtD
Mepivacaine—Body temperature increased—Gemcitabine—kidney cancer	0.00104	0.00209	CcSEcCtD
Mepivacaine—Tremor—Capecitabine—kidney cancer	0.00104	0.00208	CcSEcCtD
Mepivacaine—Hypotension—Paclitaxel—kidney cancer	0.00103	0.00206	CcSEcCtD
Mepivacaine—Headache—Sunitinib—kidney cancer	0.00103	0.00206	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—EPAS1—kidney cancer	0.00102	0.00203	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EPAS1—kidney cancer	0.00102	0.00203	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HNF1A—kidney cancer	0.00102	0.00203	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HNF1A—kidney cancer	0.00102	0.00203	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Vincristine—kidney cancer	0.00102	0.00205	CcSEcCtD
Mepivacaine—Nausea—Sorafenib—kidney cancer	0.00101	0.00203	CcSEcCtD
Mepivacaine—Asthenia—Vincristine—kidney cancer	0.000993	0.002	CcSEcCtD
Mepivacaine—Syncope—Capecitabine—kidney cancer	0.000991	0.00199	CcSEcCtD
Mepivacaine—Paraesthesia—Paclitaxel—kidney cancer	0.000987	0.00198	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—kidney cancer	0.000985	0.00198	CcSEcCtD
Mepivacaine—Somnolence—Paclitaxel—kidney cancer	0.000977	0.00196	CcSEcCtD
Mepivacaine—Nausea—Sunitinib—kidney cancer	0.000972	0.00195	CcSEcCtD
Mepivacaine—Loss of consciousness—Capecitabine—kidney cancer	0.000972	0.00195	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—PAK1—kidney cancer	0.000967	0.00193	CbGpPWpGaD
Mepivacaine—Hypertension—Capecitabine—kidney cancer	0.000954	0.00192	CcSEcCtD
Mepivacaine—Asthenia—Gemcitabine—kidney cancer	0.000942	0.00189	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—HNF1B—kidney cancer	0.000939	0.00187	CbGpPWpGaD
Mepivacaine—Anxiety—Capecitabine—kidney cancer	0.000938	0.00189	CcSEcCtD
Mepivacaine—Pruritus—Gemcitabine—kidney cancer	0.000929	0.00187	CcSEcCtD
Mepivacaine—Nausea—Dactinomycin—kidney cancer	0.00092	0.00185	CcSEcCtD
Mepivacaine—Dizziness—Vincristine—kidney cancer	0.000915	0.00184	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—kidney cancer	0.000912	0.00183	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—SPTBN4—kidney cancer	0.000907	0.00181	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—L1CAM—kidney cancer	0.000907	0.00181	CbGpPWpGaD
Mepivacaine—Oedema—Capecitabine—kidney cancer	0.000902	0.00181	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—HNF1B—kidney cancer	0.000898	0.00179	CbGpPWpGaD
Mepivacaine—Shock—Capecitabine—kidney cancer	0.000888	0.00178	CcSEcCtD
Mepivacaine—Tachycardia—Capecitabine—kidney cancer	0.000881	0.00177	CcSEcCtD
Mepivacaine—Vomiting—Vincristine—kidney cancer	0.00088	0.00177	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—kidney cancer	0.000874	0.00176	CcSEcCtD
Mepivacaine—Urticaria—Paclitaxel—kidney cancer	0.000873	0.00176	CcSEcCtD
Mepivacaine—Hyperhidrosis—Capecitabine—kidney cancer	0.000872	0.00175	CcSEcCtD
Mepivacaine—Body temperature increased—Paclitaxel—kidney cancer	0.000869	0.00175	CcSEcCtD
Mepivacaine—Headache—Vincristine—kidney cancer	0.000867	0.00174	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—HNF1B—kidney cancer	0.000863	0.00172	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HNF1B—kidney cancer	0.000863	0.00172	CbGpPWpGaD
Mepivacaine—Hypotension—Capecitabine—kidney cancer	0.000843	0.00169	CcSEcCtD
Mepivacaine—Vomiting—Gemcitabine—kidney cancer	0.000835	0.00168	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—kidney cancer	0.000833	0.00167	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—CTNNA1—kidney cancer	0.000832	0.00166	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HNF1B—kidney cancer	0.000832	0.00166	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HNF1B—kidney cancer	0.000832	0.00166	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—MAPK3—kidney cancer	0.00083	0.00165	CbGpPWpGaD
Mepivacaine—Headache—Gemcitabine—kidney cancer	0.000823	0.00165	CcSEcCtD
Mepivacaine—Nausea—Vincristine—kidney cancer	0.000822	0.00165	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000818	0.00163	CbGpPWpGaD
Mepivacaine—Paraesthesia—Capecitabine—kidney cancer	0.00081	0.00163	CcSEcCtD
Mepivacaine—Hypersensitivity—Paclitaxel—kidney cancer	0.00081	0.00163	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—PAX6—kidney cancer	0.000796	0.00158	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CER1—kidney cancer	0.000793	0.00158	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—MAPK1—kidney cancer	0.00079	0.00157	CbGpPWpGaD
Mepivacaine—Asthenia—Paclitaxel—kidney cancer	0.000789	0.00159	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—PAK1—kidney cancer	0.000782	0.00156	CbGpPWpGaD
Mepivacaine—Nausea—Gemcitabine—kidney cancer	0.00078	0.00157	CcSEcCtD
Mepivacaine—Pruritus—Paclitaxel—kidney cancer	0.000778	0.00156	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—kidney cancer	0.000763	0.00153	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—PAK1—kidney cancer	0.000748	0.00149	CbGpPWpGaD
Mepivacaine—Chills—Doxorubicin—kidney cancer	0.000735	0.00148	CcSEcCtD
Mepivacaine—Dizziness—Paclitaxel—kidney cancer	0.000727	0.00146	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—PAK1—kidney cancer	0.000719	0.00143	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—PAK1—kidney cancer	0.000719	0.00143	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EPAS1—kidney cancer	0.000717	0.00143	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HNF1A—kidney cancer	0.000717	0.00143	CbGpPWpGaD
Mepivacaine—Urticaria—Capecitabine—kidney cancer	0.000717	0.00144	CcSEcCtD
Mepivacaine—Body temperature increased—Capecitabine—kidney cancer	0.000713	0.00143	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—kidney cancer	0.000713	0.00143	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—kidney cancer	0.000699	0.00141	CcSEcCtD
Mepivacaine—Vomiting—Paclitaxel—kidney cancer	0.000699	0.0014	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—PAK1—kidney cancer	0.000693	0.00138	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—PAK1—kidney cancer	0.000693	0.00138	CbGpPWpGaD
Mepivacaine—Nervousness—Doxorubicin—kidney cancer	0.000692	0.00139	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—PAK1—kidney cancer	0.00069	0.00137	CbGpPWpGaD
Mepivacaine—Back pain—Doxorubicin—kidney cancer	0.000689	0.00139	CcSEcCtD
Mepivacaine—Headache—Paclitaxel—kidney cancer	0.000689	0.00138	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—CTNNA1—kidney cancer	0.000673	0.00134	CbGpPWpGaD
Mepivacaine—Vision blurred—Doxorubicin—kidney cancer	0.000672	0.00135	CcSEcCtD
Mepivacaine—SCN9A—L1CAM interactions—MAPK3—kidney cancer	0.000671	0.00134	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Capecitabine—kidney cancer	0.000665	0.00134	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—kidney cancer	0.000655	0.00132	CcSEcCtD
Mepivacaine—Nausea—Paclitaxel—kidney cancer	0.000653	0.00131	CcSEcCtD
Mepivacaine—Asthenia—Capecitabine—kidney cancer	0.000647	0.0013	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—PAX6—kidney cancer	0.000644	0.00128	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNA1—kidney cancer	0.000643	0.00128	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—MAPK3—kidney cancer	0.000642	0.00128	CbGpPWpGaD
Mepivacaine—Syncope—Doxorubicin—kidney cancer	0.000639	0.00128	CcSEcCtD
Mepivacaine—SCN9A—L1CAM interactions—MAPK1—kidney cancer	0.000639	0.00127	CbGpPWpGaD
Mepivacaine—Pruritus—Capecitabine—kidney cancer	0.000638	0.00128	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—kidney cancer	0.000626	0.00126	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—CTNNA1—kidney cancer	0.000618	0.00123	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNA1—kidney cancer	0.000618	0.00123	CbGpPWpGaD
Mepivacaine—Convulsion—Doxorubicin—kidney cancer	0.000617	0.00124	CcSEcCtD
Mepivacaine—SCN2A—L1CAM interactions—MAPK3—kidney cancer	0.000617	0.00123	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—MAPK3—kidney cancer	0.000617	0.00123	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PAX6—kidney cancer	0.000616	0.00123	CbGpPWpGaD
Mepivacaine—Hypertension—Doxorubicin—kidney cancer	0.000615	0.00124	CcSEcCtD
Mepivacaine—SCN3A—L1CAM interactions—MAPK1—kidney cancer	0.000611	0.00122	CbGpPWpGaD
Mepivacaine—Anxiety—Doxorubicin—kidney cancer	0.000605	0.00122	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—KDR—kidney cancer	0.000602	0.0012	CbGpPWpGaD
Mepivacaine—Dizziness—Capecitabine—kidney cancer	0.000597	0.0012	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—CTNNA1—kidney cancer	0.000596	0.00119	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNA1—kidney cancer	0.000596	0.00119	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—MAPK3—kidney cancer	0.000595	0.00118	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—MAPK3—kidney cancer	0.000595	0.00118	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PAX6—kidney cancer	0.000592	0.00118	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PAX6—kidney cancer	0.000592	0.00118	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MET—kidney cancer	0.000589	0.00117	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—MAPK1—kidney cancer	0.000587	0.00117	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—MAPK1—kidney cancer	0.000587	0.00117	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HNF1B—kidney cancer	0.000585	0.00116	CbGpPWpGaD
Mepivacaine—Oedema—Doxorubicin—kidney cancer	0.000582	0.00117	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000582	0.00117	CcSEcCtD
Mepivacaine—Vomiting—Capecitabine—kidney cancer	0.000574	0.00115	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—kidney cancer	0.000572	0.00115	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—PAX6—kidney cancer	0.000571	0.00114	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PAX6—kidney cancer	0.000571	0.00114	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000569	0.00113	CbGpPWpGaD
Mepivacaine—Tachycardia—Doxorubicin—kidney cancer	0.000568	0.00114	CcSEcCtD
Mepivacaine—SCN10A—L1CAM interactions—MAPK1—kidney cancer	0.000566	0.00113	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—MAPK1—kidney cancer	0.000566	0.00113	CbGpPWpGaD
Mepivacaine—Headache—Capecitabine—kidney cancer	0.000565	0.00114	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000562	0.00113	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—PAK1—kidney cancer	0.000558	0.00111	CbGpPWpGaD
Mepivacaine—Hypotension—Doxorubicin—kidney cancer	0.000543	0.00109	CcSEcCtD
Mepivacaine—Nausea—Capecitabine—kidney cancer	0.000536	0.00108	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—PAK1—kidney cancer	0.000534	0.00106	CbGpPWpGaD
Mepivacaine—Paraesthesia—Doxorubicin—kidney cancer	0.000522	0.00105	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—kidney cancer	0.000517	0.00104	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—PAK1—kidney cancer	0.000513	0.00102	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PAK1—kidney cancer	0.000513	0.00102	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000495	0.000985	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PAK1—kidney cancer	0.000495	0.000985	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PAK1—kidney cancer	0.000487	0.00097	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KDR—kidney cancer	0.000487	0.000969	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MET—kidney cancer	0.000476	0.000948	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KDR—kidney cancer	0.000466	0.000927	CbGpPWpGaD
Mepivacaine—Urticaria—Doxorubicin—kidney cancer	0.000462	0.000929	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—kidney cancer	0.00046	0.000924	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—MET—kidney cancer	0.000456	0.000907	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KDR—kidney cancer	0.000447	0.00089	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KDR—kidney cancer	0.000447	0.00089	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MET—kidney cancer	0.000438	0.000871	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MET—kidney cancer	0.000438	0.000871	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—RAF1—kidney cancer	0.000435	0.000866	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KDR—kidney cancer	0.000431	0.000859	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KDR—kidney cancer	0.000431	0.000859	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—ERBB2—kidney cancer	0.000431	0.000857	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KDR—kidney cancer	0.00043	0.000855	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Doxorubicin—kidney cancer	0.000428	0.000861	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—MET—kidney cancer	0.000422	0.00084	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MET—kidney cancer	0.000422	0.00084	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MET—kidney cancer	0.00042	0.000837	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNA1—kidney cancer	0.000419	0.000834	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—MAPK3—kidney cancer	0.000418	0.000832	CbGpPWpGaD
Mepivacaine—Asthenia—Doxorubicin—kidney cancer	0.000417	0.000839	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—kidney cancer	0.000411	0.000827	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—PAX6—kidney cancer	0.000401	0.000798	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—MAPK1—kidney cancer	0.000398	0.000792	CbGpPWpGaD
Mepivacaine—Dizziness—Doxorubicin—kidney cancer	0.000385	0.000773	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—kidney cancer	0.00037	0.000743	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—kidney cancer	0.000364	0.000732	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—RAF1—kidney cancer	0.000352	0.000701	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—ERBB2—kidney cancer	0.000348	0.000693	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PAK1—kidney cancer	0.000348	0.000692	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KDR—kidney cancer	0.000347	0.000691	CbGpPWpGaD
Mepivacaine—Nausea—Doxorubicin—kidney cancer	0.000345	0.000694	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000343	0.000683	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000341	0.000678	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MET—kidney cancer	0.00034	0.000677	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—RAF1—kidney cancer	0.000337	0.00067	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—ERBB2—kidney cancer	0.000333	0.000663	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KDR—kidney cancer	0.000332	0.000661	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—kidney cancer	0.000332	0.00066	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MET—kidney cancer	0.000325	0.000647	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—RAF1—kidney cancer	0.000323	0.000644	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—RAF1—kidney cancer	0.000323	0.000644	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ERBB2—kidney cancer	0.00032	0.000637	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ERBB2—kidney cancer	0.00032	0.000637	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—kidney cancer	0.000319	0.000635	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—kidney cancer	0.000319	0.000635	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK3—kidney cancer	0.000314	0.000624	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—kidney cancer	0.000312	0.000622	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—kidney cancer	0.000312	0.000622	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—RAF1—kidney cancer	0.000312	0.000621	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—RAF1—kidney cancer	0.000312	0.000621	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RAF1—kidney cancer	0.000311	0.000618	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RELA—kidney cancer	0.000309	0.000615	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ERBB2—kidney cancer	0.000309	0.000614	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ERBB2—kidney cancer	0.000309	0.000614	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—kidney cancer	0.000308	0.000613	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—kidney cancer	0.000308	0.000613	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ERBB2—kidney cancer	0.000307	0.000612	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—kidney cancer	0.000303	0.000604	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—kidney cancer	0.000301	0.0006	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MET—kidney cancer	0.000301	0.0006	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.0003	0.000597	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK1—kidney cancer	0.000299	0.000594	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—kidney cancer	0.000297	0.000591	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—kidney cancer	0.000282	0.000561	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CTNNB1—kidney cancer	0.000269	0.000535	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—kidney cancer	0.000268	0.000534	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—kidney cancer	0.000257	0.000511	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK3—kidney cancer	0.000254	0.000505	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RAF1—kidney cancer	0.000251	0.0005	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RELA—kidney cancer	0.00025	0.000498	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ERBB2—kidney cancer	0.000249	0.000495	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—kidney cancer	0.000246	0.000491	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—kidney cancer	0.000246	0.000491	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK3—kidney cancer	0.000243	0.000483	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK1—kidney cancer	0.000241	0.000481	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RAF1—kidney cancer	0.00024	0.000478	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RELA—kidney cancer	0.000239	0.000476	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ERBB2—kidney cancer	0.000238	0.000473	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—kidney cancer	0.000238	0.000473	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—kidney cancer	0.000238	0.000473	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—kidney cancer	0.000237	0.000471	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK3—kidney cancer	0.000233	0.000464	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK3—kidney cancer	0.000233	0.000464	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK1—kidney cancer	0.000231	0.00046	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RAF1—kidney cancer	0.000231	0.000459	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RAF1—kidney cancer	0.000231	0.000459	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RELA—kidney cancer	0.00023	0.000457	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RELA—kidney cancer	0.00023	0.000457	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ERBB2—kidney cancer	0.000228	0.000455	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ERBB2—kidney cancer	0.000228	0.000455	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—kidney cancer	0.000228	0.000454	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK3—kidney cancer	0.000225	0.000447	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK3—kidney cancer	0.000225	0.000447	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK3—kidney cancer	0.000224	0.000446	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RAF1—kidney cancer	0.000223	0.000443	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RAF1—kidney cancer	0.000223	0.000443	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK1—kidney cancer	0.000222	0.000442	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK1—kidney cancer	0.000222	0.000442	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RELA—kidney cancer	0.000222	0.000441	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RELA—kidney cancer	0.000222	0.000441	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ERBB2—kidney cancer	0.00022	0.000438	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ERBB2—kidney cancer	0.00022	0.000438	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—RAF1—kidney cancer	0.000219	0.000436	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—kidney cancer	0.000218	0.000434	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CTNNB1—kidney cancer	0.000217	0.000433	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ERBB2—kidney cancer	0.000217	0.000432	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—kidney cancer	0.000216	0.000431	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK1—kidney cancer	0.000214	0.000426	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK1—kidney cancer	0.000214	0.000426	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK1—kidney cancer	0.000213	0.000424	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—kidney cancer	0.000212	0.000422	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—kidney cancer	0.00021	0.000417	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—kidney cancer	0.00021	0.000417	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNB1—kidney cancer	0.000208	0.000414	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—kidney cancer	0.000202	0.000402	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—kidney cancer	0.000202	0.000402	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—kidney cancer	0.000201	0.0004	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CTNNB1—kidney cancer	0.0002	0.000398	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNB1—kidney cancer	0.0002	0.000398	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CTNNB1—kidney cancer	0.000193	0.000383	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNB1—kidney cancer	0.000193	0.000383	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—kidney cancer	0.000191	0.000381	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—kidney cancer	0.000183	0.000364	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK3—kidney cancer	0.000181	0.00036	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—kidney cancer	0.000176	0.00035	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—kidney cancer	0.000176	0.00035	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK3—kidney cancer	0.000173	0.000345	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK1—kidney cancer	0.000172	0.000343	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—kidney cancer	0.00017	0.000338	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—kidney cancer	0.00017	0.000338	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—kidney cancer	0.000167	0.000333	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK3—kidney cancer	0.000166	0.000331	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK3—kidney cancer	0.000166	0.000331	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK1—kidney cancer	0.000165	0.000328	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—kidney cancer	0.000163	0.000324	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK3—kidney cancer	0.00016	0.000319	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK3—kidney cancer	0.00016	0.000319	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK1—kidney cancer	0.000158	0.000315	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK1—kidney cancer	0.000158	0.000315	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK3—kidney cancer	0.000158	0.000315	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RAF1—kidney cancer	0.000156	0.000311	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RELA—kidney cancer	0.000156	0.00031	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—kidney cancer	0.000156	0.00031	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ERBB2—kidney cancer	0.000155	0.000308	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK1—kidney cancer	0.000153	0.000304	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK1—kidney cancer	0.000153	0.000304	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK1—kidney cancer	0.00015	0.000299	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—kidney cancer	0.00015	0.000298	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—kidney cancer	0.00015	0.000298	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—kidney cancer	0.000144	0.000287	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—kidney cancer	0.000144	0.000287	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—kidney cancer	0.000142	0.000283	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNB1—kidney cancer	0.000135	0.00027	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—kidney cancer	0.000119	0.000237	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK3—kidney cancer	0.000113	0.000224	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK1—kidney cancer	0.000107	0.000214	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—kidney cancer	0.000101	0.000202	CbGpPWpGaD
